Medpace Holdings (MEDP) Receivables - Net (2015 - 2026)

Medpace Holdings (MEDP) has 12 years of Receivables - Net data on file, last reported at $441.8 million in Q2 2026.

• Quarterly Receivables - Net rose 16.9% year-over-year to $441.8 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $441.8 million (up 16.9% YoY) and the FY2025 annual result came in at $402.1 million, up 35.63% from the prior year.
• Receivables - Net grew to $441.8 million in Q2 2026, from $394.6 million in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $441.8 million in Q2 2026 to a low of $224.8 million in Q1 2022.
• A 5-year average of $308.5 million and a median of $297.3 million in 2024 frame the typical range for Receivables - Net.
• Annual changes were most pronounced in 2022 — Receivables - Net soared 40.48% — and 2024, when it dropped 0.66%.
• Tracing MEDP's Receivables - Net over 5 years: stood at $253.4 million in 2022, then rose by 17.76% to $298.4 million in 2023, then retreated by 0.66% to $296.4 million in 2024, then surged by 35.63% to $402.1 million in 2025, then increased by 9.88% to $441.8 million in 2026.
• The last three Receivables - Net figures came in at $441.8 million (Q2 2026), $394.6 million (Q1 2026), and $402.1 million (Q4 2025), per Business Quant data.